Oncology Molecular Diagnostics Market by Product Type, Distribution Channel, End User 2021-2026

1
Global Oncology Molecular Diagnostics Market
Research and Forecast Report 2021-2026




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Oncology Molecular Diagnostics Market
Research Report According to the latest report
by IMARC Group, titled "Oncology Molecular
Diagnostics Market Global Industry Trends,
Share, Size, Growth, Opportunity and Forecast
2021-2026," the global oncology molecular
diagnostics market reached a strong growth in
2020. Oncology molecular diagnostics is a part
of laboratory medicine that involves analyzing
biological markers for the detection of cancer
cells in an individual. In this process, blood,
saliva, and tumor tissue sample tests are
performed on the patient for measuring specific
genetic sequences in the DNA, RNA and cell
proteins. They are utilized for performing
rapid analysis of the condition and providing
detailed critical information regarding it. The
quantitative measurements offered by the
diagnostics are essential in understanding the
stage and available effective therapeutic options
for cancer. This aids in determining the right
course of personalized treatment for the patient
by making informed medical decisions for a better
outcome. Request Free Sample Report
https//www.imarcgroup.com/oncology-molecular-diag
nostics-market/requestsample
4
Report Description and Highlights
Report Description
Global Oncology Molecular Diagnostics Market
Trends The market is primarily driven by the
growing prevalence of different forms of cancer
across the globe. This can be attributed to the
sedentary lifestyles led by the majority of the
population, along with the high tobacco and
alcohol uptake by the masses. Consequently, there
is a significant increase in the demand for
efficient diagnostic solutions, thereby providing
a thrust to the market growth. Apart from this,
the rising awareness regarding early cancer
detection among individuals is acting as another
major growth-inducing factor. Moreover, there has
also been a considerable increase in the
geriatric population on the global level. This,
along with the growing investments by numerous
private and public organizations to develop the
oncology infrastructure across healthcare
facilities, is creating a positive outlook for
the market. Numerous players have also
introduced technologically advanced diagnostics
products in the market. Since these products
offer enhanced accuracy and speed in terms of
diagnosis while being affordable, they are
gaining widespread prominence across the
healthcare sector. Some of the other factors
catalyzing the market growth include the
increasing penetration of healthcare insurance in
numerous developing countries and the rising
trend of medical tourism on the global
level. Looking forward, the market value is
projected to reach a strong growth during the
forecast period (2021-2026).

5
Report Description and Highlights
Report Description

• Market Summary
• Breakup by Cancer Type
• Breast Cancer
• Prostate Cancer
• Colorectal Cancer
• Cervical Cancer
• Liver Cancer
• Lung Cancer
• Blood Cancer
• Others
•  
• Breakup by Product
• Instruments
• Reagents
• Others
• Breakup by Technology
• Polymerase Chain Reaction (PCR)
• In Situ Hybridization

6
Report Description and Highlights
Report Description

• Mass Spectrometry
• DNA and NGS Sequencing
• Transcription Mediated Amplification (TMA)
• Others
• Breakup by End-User
• Hospitals and Clinics
• Reference Laboratories
• Others
• Breakup by Region
• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea

7
Report Description and Highlights
Report Description

• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Argentina
• Columbia
• Chile
• Peru
• Others

8
Report Description and Highlights
Report Description

• Middle East and Africa Turkey
• Saudi Arabia
• Iran
• United Arab Emirates
• Others
• Note We are updating our reports, If you want
  latest primary and secondary data (2021-2026)
  with Cost Module, Business Strategy, Distribution
  Channel, etc. Click request free sample report.
• Competitive Landscape with Key Players
• Agilent Technologies Inc.
• Abbott Laboratories
• Bayer AG
• BD (Becton, Dickinson and Company)
• Cepheid Inc. (Danaher Corporation)
• F. Hoffmann-La Roche AG
• Hologic Inc.
• Qiagen N.V.
• Siemens Healthcare
• Sysmex Corporation.

9
Report Description and Highlights
Report Description

View Full Report with TOC List of Figure
https//www.imarcgroup.com/oncology-molecular-diag
nostics-market
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
13

Contact Us